Search Results - "CLOUSTON, ANDREW D"

Refine Results
  1. 1

    Links Between Hepatic Fibrosis, Ductular Reaction, and Progenitor Cell Expansion by Williams, Michael J, Clouston, Andrew D, Forbes, Stuart J

    Published in Gastroenterology (New York, N.Y. 1943) (01-02-2014)
    “…Interactions between cells and their extracellular matrix have been shown to be crucial in a wide range of biological processes, including the proliferation…”
    Get full text
    Journal Article
  2. 2

    The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease by Gadd, Victoria L., Skoien, Richard, Powell, Elizabeth E., Fagan, Kevin J., Winterford, Clay, Horsfall, Leigh, Irvine, Katharine, Clouston, Andrew D.

    Published in Hepatology (Baltimore, Md.) (01-04-2014)
    “…Although nonalcoholic fatty liver disease (NAFLD) is conventionally assessed histologically for lobular features of inflammation, development of portal…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Ductular reactions in human liver: Diversity at the interface by Gouw, Annette S. H., Clouston, Andrew D., Theise, Neil D.

    Published in Hepatology (Baltimore, Md.) (01-11-2011)
    “…Interest in hepatic ductular reactions (DRs) has risen in recent years because of a greater appreciation of their potential roles in regeneration,…”
    Get full text
    Journal Article
  6. 6

    A clinicopathological and molecular analysis of 200 traditional serrated adenomas by Bettington, Mark L, Walker, Neal I, Rosty, Christophe, Brown, Ian S, Clouston, Andrew D, McKeone, Diane M, Pearson, Sally-Ann, Klein, Kerenaftali, Leggett, Barbara A, Whitehall, Vicki LJ

    Published in Modern pathology (01-03-2015)
    “…The traditional serrated adenoma is the least common colorectal serrated polyp. The clinicopathological features and molecular drivers of these polyps require…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Steatosis: co-factor in other liver diseases by Powell, Elizabeth E, Jonsson, Julie R, Clouston, Andrew D

    Published in Hepatology (Baltimore, Md.) (01-07-2005)
    “…The prevalence of fatty liver is rising in association with the global increase in obesity and type 2 diabetes. In the past, simple steatosis was regarded as…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Ductular reaction in hereditary hemochromatosis: The link between hepatocyte senescence and fibrosis progression by Wood, Marnie J., Gadd, Victoria L., Powell, Lawrie W., Ramm, Grant A., Clouston, Andrew D.

    Published in Hepatology (Baltimore, Md.) (01-03-2014)
    “…The development of portal fibrosis following the iron loading of hepatocytes is the first stage of fibrogenesis in hereditary hemochromatosis. In other chronic…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Magnetic resonance imaging and spectroscopy for monitoring liver steatosis by Cowin, Gary J., Jonsson, Julie R., Bauer, Judith D., Ash, Susan, Ali, Azmat, Osland, Emma J., Purdie, David M., Clouston, Andrew D., Powell, Elizabeth E., Galloway, Graham J.

    Published in Journal of magnetic resonance imaging (01-10-2008)
    “…Purpose To compare noninvasive MRI and magnetic resonance spectroscopy (MRS) methods with liver biopsy to quantify liver fat content. Materials and Methods…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Pathologic Features of Hereditary Cholestatic Diseases by Clouston, Andrew D., MBBS, PhD, FRCPA

    Published in Surgical pathology clinics (01-06-2018)
    “…Abstract The inherited diseases causing conjugated hyperbilirubinemia are diverse, with variability in clinical severity, histologic appearance, and time of…”
    Get full text
    Journal Article
  18. 18

    Type I-IFNs control GVHD and GVL responses after transplantation by Robb, Renee J., Kreijveld, Ellen, Kuns, Rachel D., Wilson, Yana A., Olver, Stuart D., Don, Alistair L.J., Raffelt, Neil C., De Weerd, Nicole A., Lineburg, Katie E., Varelias, Antiopi, Markey, Kate A., Koyama, Motoko, Clouston, Andrew D., Hertzog, Paul J., MacDonald, Kelli P.A., Hill, Geoffrey R.

    Published in Blood (22-09-2011)
    “…Although the effects of type II-IFN (IFN-γ) on GVHD and leukemia relapse are well studied, the effects of type I-interferon (type I-IFN, IFN-α/β) remain…”
    Get full text
    Journal Article
  19. 19

    Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C by Jonsson, Julie R., Barrie, Helen D., O'Rourke, Peter, Clouston, Andrew D., Powell, Elizabeth E.

    Published in Hepatology (Baltimore, Md.) (01-07-2008)
    “…Obesity and fatty liver are commonly observed among patients with chronic hepatitis C virus (HCV) and are risk factors for increased hepatic fibrosis. Obesity…”
    Get full text
    Journal Article
  20. 20

    Promoting regulation via the inhibition of DNAM-1 after transplantation by Koyama, Motoko, Kuns, Rachel D., Olver, Stuart D., Lineburg, Katie E., Lor, Mary, Teal, Bianca E., Raffelt, Neil C., Leveque, Lucie, Chan, Christopher J., Robb, Renee J., Markey, Kate A., Alexander, Kylie A., Varelias, Antiopi, Clouston, Andrew D., Smyth, Mark J., MacDonald, Kelli P.A., Hill, Geoffrey R.

    Published in Blood (25-04-2013)
    “…Donor T cells play pivotal roles in graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects following bone marrow transplantation (BMT). DNAX…”
    Get full text
    Journal Article